1 day agoAnavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update
Mar 18Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia